Related Experiment Video

Updated: Jan 13, 2026

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

Inhibition of human Nav1.4 by D-amino acid modified μ-CnIIIC

Renfei Wu¹, Zhuying Wang², Yuan Quan³

¹Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China; PeptiOrigin Biotechnology Co., Ltd., Shenzhen 518000, China.

Bioorganic Chemistry

|January 11, 2026

Abstract

None:

Voltage-gated sodium channel Nav1.4 is a key target for neuromuscular disorders; however, existing peptide inhibitors face stability challenges. We systematically investigated the effect of D-amino acid modification on the inhibition of the human voltage-gated sodium channel Na_V1.4 by μ-CnIIIC. The N-terminal pyroglutamic acid (pGlu) of wild-type μ-CnIIIC was replaced with D-arginine (Dar), D-lysine (Dly), or D-histidine (Dhi) via solid-phase peptide synthesis, yielding the derivatives dR-μ-CnIIIC, dK-μ-CnIIIC, and dH-μ-CnIIIC, respectively. Voltage patch clamp experiments demonstrated that dR-μ-CnIIIC, which inhibited Na_V1.4 in its resting state, exhibited superior inhibitory activity, with an IC₅₀ valueof 54.14 ± 6.26 nM (P < 0.01) compared to 96.37 ± 10.68 nM for the wild-type peptide. Molecular docking and kinetic simulations revealed that dR-μ-CnIIIC formed strong electrostatic interactions and hydrogen-bonding networks with the hNa_V1.4 protein α-subunits Glu352, Asp1514, and Asp1515, as well as the β-subunit Glu48, thereby enhancing its binding affinity. Serum stability assays further demonstrated that D-amino acid modification substantially enhanced the resistance to protease degradation, with dR-μ-CnIIIC retaining 31.7% activity after 480 min. This study provides a rational design strategy for the development of efficient and stable sodium channel-targeted therapeutic agents. Moreover, this D-amino acid substitution strategy may be generalizable to other conotoxin-based therapeutics.

Keywords:

D-amino acid modification hNa(V)1.4 Μ-CnIIIC

More Related Videos

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

Preparation and Utilization of Freshly Isolated Human Detrusor Smooth Muscle Cells for Characterization of 9-Phenanthrol-Sensitive Cation Currents

Preparation and Utilization of Freshly Isolated Human Detrusor Smooth Muscle Cells for Characterization of 9-Phenanthrol-Sensitive Cation Currents

Published on: January 31, 2020

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...

Ligand-gated Ion Channels

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...

Antihypertensive Drugs: Action of Calcium Channel Blockers

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...

Cholinergic Receptors: Nicotinic

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...

Articles linked to this work by shared authors, journal, and citation graph.

CKLF1 Serves as a Pivotal Mediator of Blood-Brain Barrier Disruption and Neuroinflammation via PI3K/AKT/mTOR Signaling in Ischemic Stroke.

Molecular neurobiology·2026

Comparative multiphase CT radiomics for differentiating isolated hepatic metastasis from intrahepatic cholangiocarcinoma: a two-center study of native, subtraction, peritumoral, and fusion models.

Frontiers in oncology·2026

Integrated Comparative Genomics and Population Genomics Reveal the Genomic and Epigenomic Basis of Barley (Hordeum vulgare) Evolution and Domestication.

Plants (Basel, Switzerland)·2026

Learning Mechanistic Reasoning for Chemical Reactions with Large Language Models.

ArXiv·2026

Toward Predicting Solubility of Arbitrary Solutes in Arbitrary Solvents: Prediction of Density and Refractive Index Using Machine Learning Algorithms with Global Sensitivity Analysis.

Organic process research & development·2026

Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications.

Drug metabolism and disposition: the biological fate of chemicals·2026

See all related articles